Skip to Main Content

Author Details

Ho Min Kim
Center for Biomolecular and Cellular Structure, Institute for Basic Science (IBS)
2003
113
34
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37015934Single-molecule fingerprinting of protein-drug interaction using a funneled biological nanopore.Nat Commun2023
37218331[A Case of Rectal Neuroendocrine Carcinoma with Iris Metastasis].Gan To Kagaku Ryoho2023
37121976Crystal structure of LRG1 and the functional significance of LRG1 glycan for LPHN2 activation.Exp Mol Med2023
34913730A Dynamic Substrate Pool Revealed by cryo-EM of a Lipid-Preserved Respiratory Supercomplex.Antioxid Redox Signal2022
35489740Phase II Study of S-1 and Irinotecan Plus Bevacizumab as Second-line Treatment for Patients With Metastatic Colorectal Cancer Resistant to the Fluoropyrimidine-oxaliplatin-cetuximab Regimen.Anticancer Res2022
35562586Latrophilin-2 is a novel receptor of LRG1 that rescues vascular and neurological abnormalities and restores diabetic erectile function.Exp Mol Med2022
35874766N-glycosylation of UNC93B1 at a Specific Asparagine Residue Is Required for TLR9 Signaling.Front Immunol2022
35907924Structural basis for assembly and disassembly of the IGF/IGFBP/ALS ternary complex.Nat Commun2022
36070600Clinical Impact of Two-Week Placement of a Subcutaneous Suction Drain in Preventing Incisional Surgical Site Infection in Open Gastrointestinal Surgery with Class 4 Dirty Wound: A Retrospective Study.Surg Infect (Larchmt)2022
36272973PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141<sup>+</sup> cancer-associated fibroblasts in pancreatic cancer.Nat Commun2022
33953168Mastocytosis-derived extracellular vesicles deliver miR-23a and miR-30a into pre-osteoblasts and prevent osteoblastogenesis and bone formation.Nat Commun2021
33790157[Capecitabine and Oxaliplatin(CAPOX)plus Bevacizumab as Second-Line Chemotherapy for Metastatic Colorectal Cancer].Gan To Kagaku Ryoho2021
33774526Development of an antibody-like T-cell engager based on VH-VL heterodimer formation and its application in cancer therapy.Biomaterials2021
33604941Administration Method of Adjuvant Tegafur-Uracil and Leucovorin Calcium in Patients with Resected Colorectal Cancer: A Phase III Study.Oncologist2021
34725372Structural insights into the clustering and activation of Tie2 receptor mediated by Tie2 agonistic antibody.Nat Commun2021
34514924High-yield synthesis and purification of recombinant human GABA transaminase for high-throughput screening assays.J Enzyme Inhib Med Chem2021
34223817Soluble Fas ligand drives autoantibody-induced arthritis by binding to DR5/TRAIL-R2.Elife2021
34251825Uncovering the Conformational Distribution of a Small Protein with Nanoparticle-Aided Cryo-Electron Microscopy Sampling.J Phys Chem Lett2021
34003804Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19.J Clin Invest2021
31479875Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency.Cytokine2020
31924789Non-invasive optical control of endogenous Ca<sup>2+</sup> channels in awake mice.Nat Commun2020
33253537Metal-Mediated Protein Assembly Using a Genetically Incorporated Metal-Chelating Amino Acid.Biomacromolecules2020
33142113Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2.Cell Stem Cell2020
33196778Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept.Invest Ophthalmol Vis Sci2020
32856385Multivalent-Interaction-Driven Assembly of Discrete, Flexible, and Asymmetric Supramolecular Protein Nano-Prisms.Angew Chem Int Ed Engl2020
32910525ClpL is a functionally active tetradecameric AAA+ chaperone, distinct from hexameric/dodecameric ones.FASEB J2020
32616061Neural circuit analysis using a novel intersectional split intein-mediated split-Cre recombinase system.Mol Brain2020
30872732Pro-angiogenic Ginsenosides F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1.Sci Rep2019
32110335Fabrication of rigidity and space variable protein oligomers with two peptide linkers.Chem Sci2019
30822649Synaptic organizer: Slitrks and type IIa receptor protein tyrosine phosphatases.Curr Opin Struct Biol2019
29559443Pericyte-Derived Dickkopf2 Regenerates Damaged Penile Neurovasculature Through an Angiopoietin-1-Tie2 Pathway.Diabetes2018
30062865Fabrication of Oligomeric Avidin Scaffolds for Valency-Controlled Surface Display of Functional Ligands.Angew Chem Int Ed Engl2018
30008201Structural Basis for LAR-RPTP-Mediated Synaptogenesis.Mol Cells2018
30348793Coiled-coil structure-dependent interactions between polyQ proteins and Foxo lead to dendrite pathology and behavioral defects.Proc Natl Acad Sci U S A2018
30332623HMGB1: LPS Delivery Vehicle for Caspase-11-Mediated Pyroptosis.Immunity2018
29644459A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study.Cancer Chemother Pharmacol2018
29448101Neuronal calcium channel α<sub>1</sub> subunit interacts with AMPA receptor, increasing its cell surface localisation.Biochem Biophys Res Commun2018
29359486Four-fold Channel-Nicked Human Ferritin Nanocages for Active Drug Loading and pH-Responsive Drug Release.Angew Chem Int Ed Engl2018
29679794Multi-paratopic VEGF decoy receptor have superior anti-tumor effects through anti-EGFRs and targeted anti-angiogenic activities.Biomaterials2018
29508026A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trial.Cancer Chemother Pharmacol2018
27465476Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea.Int J Clin Oncol2017
28115037Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.BMB Rep2017
29259207Dickkopf2 rescues erectile function by enhancing penile neurovascular regeneration in a mouse model of cavernous nerve injury.Sci Rep2017
29081732LAR-RPTP Clustering Is Modulated by Competitive Binding between Synaptic Adhesion Partners and Heparan Sulfate.Front Mol Neurosci2017
29269727Pro-inflammatory hepatic macrophages generate ROS through NADPH oxidase 2 via endocytosis of monomeric TLR4-MD2 complex.Nat Commun2017
29348836Vitexin confers HSF-1 mediated autophagic cell death by activating JNK and ApoL1 in colorectal carcinoma cells.Oncotarget2017
28510802Phase I/II study of bi-weekly XELIRI plus bevacizumab treatment in patients with metastatic colorectal cancer resistant to oxaliplatin-based first-line chemotherapy.Cancer Chemother Pharmacol2017
28850637Role of the Fc Region in the Vitreous Half-Life of Anti-VEGF Drugs.Invest Ophthalmol Vis Sci2017
28641111Structural Insights into Modulation of Neurexin-Neuroligin Trans-synaptic Adhesion by MDGA1/Neuroligin-2 Complex.Neuron2017
28825216Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.Cancer Chemother Pharmacol2017
  • 1 - 50 of 113

Recommended Authors

Research Center for Nano-Biomaterials, Sichuan University
Career Start Year 2013
Number of shared co-authors 0
University of North Carolina School of Medicine
Career Start Year 2010
Number of shared co-authors 0
Institute of Insect Science and Technology, South China Normal University
Career Start Year 2006
Number of shared co-authors 0
Jilin University
Career Start Year 2005
Number of shared co-authors 0
West China Hospital, Sichuan University
Career Start Year 2005
Number of shared co-authors 0
Huaihe Hospital of Henan University
Career Start Year 2004
Number of shared co-authors 0
The University of Texas at Austin
Career Start Year 2004
Number of shared co-authors 0
McGill Research Centre for Studies in Aging
Career Start Year 2003
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 2001
Number of shared co-authors 0
College of Plant Protection, Southwest University
Career Start Year 2001
Number of shared co-authors 0
Stem Cell Translational Research Center of Tongji Hospital, Tongji University
Career Start Year 2000
Number of shared co-authors 0
the Second Affiliated Hospital of Guangzhou University of Chinese Medicine
Career Start Year 2000
Number of shared co-authors 0
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 0
Institute of Pathogens and Vectors, Dali University
Career Start Year 1998
Number of shared co-authors 0
Basic Medical College, Qingdao University
Career Start Year 1998
Number of shared co-authors 0
National Dong Hwa University
Career Start Year 1997
Number of shared co-authors 0
Obstetrics and Gynecology Hospital of Fudan University
Career Start Year 1997
Number of shared co-authors 0
Bowdoin College
Career Start Year 1997
Number of shared co-authors 0
College of Science & Industry Convergence, Ewha Womans University
Career Start Year 1997
Number of shared co-authors 0
Department of Food Bioengineering, Jeju National University
Career Start Year 1996
Number of shared co-authors 1
University of Washington
Career Start Year 1996
Number of shared co-authors 1
Ajou University
Career Start Year 1995
Number of shared co-authors 0
Beijing Tongren Hospital, Capital Medical University
Career Start Year 1995
Number of shared co-authors 0
College of Korean Medicine, Kyung Hee University
Career Start Year 1995
Number of shared co-authors 2
The Institute of Biomedical Sciences, East China Normal University
Career Start Year 1994
Number of shared co-authors 0
The University of Tokyo
Career Start Year 1992
Number of shared co-authors 2
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Xijing Hospital, The Fourth Military Medical University
Career Start Year 1992
Number of shared co-authors 2
Beijing Friendship Hospital, Capital Medical University
Career Start Year 1988
Number of shared co-authors 0
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1988
Number of shared co-authors 0

Collaborators

Quantitative Bioscience Institute, University of California san francisco
Co-authored papers 5
Co-authored papers 4
Co-authored papers 2
Haeundae Paik Hospital, Inje University College of Medicine
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
Pfizer Inc.
Co-authored papers 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 1
Co-authored papers 1
Institute for Biophysical Chemistry, Goethe-University
Co-authored papers 1
Pfizer Inc.
Co-authored papers 1
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 1
Co-authored papers 1
Seoul National University College of Medicine, Seoul National University Hospital
Co-authored papers 1
Lawrence Berkeley National Laboratory, University of California
Co-authored papers 1
Pfizer Inc.
Co-authored papers 1
School of Chemistry & Pharmaceutical Sciences, Guangxi Normal University
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Korea Advanced Institute of Science and Technology (KAIST)
Co-authored papers 1
Co-authored papers 1
The Hebrew University of Jerusalem
Co-authored papers 1
Harvard Medical School
Co-authored papers 1
Yokohama City University
Co-authored papers 1
Pfizer Inc.
Co-authored papers 1
The University of British Columbia
Co-authored papers 1